Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients
Public ClinicalTrials.gov record NCT00042354. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Open Label Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myelogenous Leukemia
Study identification
- NCT ID
- NCT00042354
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- clofarabine (IV formulation) Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2002
- Primary completion
- Not listed
- Completion
- Jul 31, 2004
- Last update posted
- Mar 4, 2015
2002 – 2004
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| Children's Hospital | Los Angeles | California | 90027 | — |
| Children's Hospital | Orange County | California | — | — |
| Children's Hospital | San Diego | California | — | — |
| Children's Hospital | Denver | Colorado | — | — |
| University of Connecticut Health Center | Hartford | Connecticut | 06106 | — |
| Children's Memorial Hospital | Chicago | Illinois | 60614 | — |
| Johns Hopkins Children's Center | Baltimore | Maryland | 21231 | — |
| Children's Hospital | St Louis | Missouri | — | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 67198 | — |
| Memorial Sloan-Kettering | New York | New York | — | — |
| Children's Hospital | Philadelphia | Pennsylvania | — | — |
| Children's Hospital | Pittsburgh | Pennsylvania | 15213 | — |
| St. Jude Children's Research Hospital | Memphis | Tennessee | — | — |
| Children's Medical Center | Dallas | Texas | — | — |
| Cook's Children's Medical Center | Fort Worth | Texas | 76104 | — |
| Texas Children's Cancer Center | Houston | Texas | — | — |
| The University of Texas M.D. Anderson Cancer Center | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00042354, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2015 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00042354 live on ClinicalTrials.gov.